Addus HomeCare (NASDAQ:ADUS) Upgraded to “Strong-Buy” at Wall Street Zen

Wall Street Zen upgraded shares of Addus HomeCare (NASDAQ:ADUSFree Report) from a buy rating to a strong-buy rating in a research note released on Saturday morning.

Several other equities research analysts have also recently commented on the company. Weiss Ratings reissued a “hold (c+)” rating on shares of Addus HomeCare in a report on Wednesday, October 8th. Barclays boosted their price objective on Addus HomeCare from $111.00 to $117.00 and gave the stock an “underweight” rating in a research note on Tuesday, November 4th. Cowen reaffirmed a “buy” rating on shares of Addus HomeCare in a research note on Wednesday, November 5th. TD Cowen boosted their price target on shares of Addus HomeCare from $139.00 to $140.00 and gave the stock a “buy” rating in a research report on Wednesday, November 5th. Finally, Truist Financial set a $135.00 price target on shares of Addus HomeCare and gave the company a “buy” rating in a report on Wednesday, January 7th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $136.90.

Read Our Latest Research Report on ADUS

Addus HomeCare Price Performance

Shares of NASDAQ ADUS opened at $107.50 on Friday. The stock has a market cap of $1.99 billion, a P/E ratio of 23.02, a P/E/G ratio of 1.29 and a beta of 0.92. The firm’s 50-day simple moving average is $112.52 and its 200 day simple moving average is $113.25. Addus HomeCare has a fifty-two week low of $88.96 and a fifty-two week high of $136.72. The company has a quick ratio of 1.66, a current ratio of 1.66 and a debt-to-equity ratio of 0.14.

Addus HomeCare (NASDAQ:ADUSGet Free Report) last released its earnings results on Monday, November 3rd. The company reported $1.56 EPS for the quarter, beating the consensus estimate of $1.53 by $0.03. The firm had revenue of $362.30 million for the quarter, compared to analysts’ expectations of $354.48 million. Addus HomeCare had a net margin of 6.36% and a return on equity of 9.53%. Addus HomeCare’s quarterly revenue was up 25.0% on a year-over-year basis. During the same quarter last year, the company earned $1.30 EPS. Equities analysts expect that Addus HomeCare will post 4.59 EPS for the current year.

Insider Buying and Selling at Addus HomeCare

In related news, EVP Darby Anderson sold 20,000 shares of the company’s stock in a transaction on Wednesday, November 19th. The stock was sold at an average price of $109.00, for a total transaction of $2,180,000.00. Following the transaction, the executive vice president directly owned 44,144 shares of the company’s stock, valued at approximately $4,811,696. The trade was a 31.18% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders sold a total of 20,316 shares of company stock worth $2,215,998 in the last quarter. Insiders own 4.50% of the company’s stock.

Hedge Funds Weigh In On Addus HomeCare

A number of large investors have recently made changes to their positions in ADUS. Larson Financial Group LLC grew its position in Addus HomeCare by 133.3% during the third quarter. Larson Financial Group LLC now owns 238 shares of the company’s stock valued at $28,000 after purchasing an additional 136 shares in the last quarter. AlphaQuest LLC purchased a new position in shares of Addus HomeCare during the 3rd quarter valued at $37,000. Wexford Capital LP acquired a new position in shares of Addus HomeCare in the third quarter worth $41,000. State of Wyoming acquired a new position in shares of Addus HomeCare in the second quarter worth $47,000. Finally, Raymond James Financial Inc. purchased a new stake in shares of Addus HomeCare during the second quarter worth $61,000. Institutional investors and hedge funds own 95.35% of the company’s stock.

About Addus HomeCare

(Get Free Report)

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.

See Also

Analyst Recommendations for Addus HomeCare (NASDAQ:ADUS)

Receive News & Ratings for Addus HomeCare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Addus HomeCare and related companies with MarketBeat.com's FREE daily email newsletter.